Affibody is a private clinical-stage Swedish biotech company focused on developing into an integrated biopharma company utilizing next generation biotherapeutics based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.
The company operates a focused experimental medicine model and currently has three clinical stage programs. The first two are therapeutic programs that targets psoriasis, and B-cell driven autoimmune diseases respectively. The third program is a diagnostic imaging program that is directed primarily towards metastatic breast cancer.
Affibody has ongoing commercial relationships with several companies such as AbClon, Alexion, Biotest, Daewoong, Daiichi Sankyo, GE Healthcare, and Swedish Orphan Biovitrum.
Affibody was founded in 1998 by researchers from the Royal Institute of Technology and the Karolinska Institute and is based in Stockholm, Sweden.
Affibody AB is a holding of Patricia Industries.
Company Details
- Employees
- 94
- Founded
- -
- Address
- Scheeles Väg, 2,sweden
- Phone
- 46 8 59 88 38 00
- re****@****ody.com
- Industry
- Biotechnology
- Website
- affibody.com
- Keywords
- biopharmaceuticals, Albumod, Affibody.
- HQ
- Haga, Stockholm
Affibody Ab Questions
Affibody Ab's helpline number is 46 8 59 88 38 00
Affibody Ab's website is affibody.com
Affibody Ab's LinkedIn profile is https://se.linkedin.com/company/affibody-ab
Affibody Ab has
94 employees.
View email and phone details for 94
employees at Affibody Ab.
Affibody Ab's industry is
Biotechnology
Affibody Ab's top competitors are
Octapharma Sweden,
Bioarctic,
Atlas Antibodies,
Biolamina,
Xbrane Biopharma Ab,
Northx Biologics,
Pelago Bioscience Ab,
Sprint Bioscience,
Anocca,
Pixelgen Technologies.
Affibody Ab's support email address is reception@affibody.com
Affibody Ab's categories are Biotechnology
Affibody Ab's founding year is 1998
